On the occasion of the presentation of its medium-term plan for 2023-26, the Clariane nursing home group has announced its main prospects for this period, after taking into account all aspects of the refinancing plan.

It is thus targeting average annual organic growth of around +5% over this period, an EBITDA margin (pre IFRS 16) up by 100 to 150 basis points by 2026, as well as financial leverage of less than three times and an LTV of 55% by the end of 2025.

Clariane affirms that its €1.5 billion refinancing plan to strengthen its financial structure is well underway, including the capital increase component which will be submitted for approval at the Combined General Meeting on June 10.

Copyright (c) 2024 CercleFinance.com. All rights reserved.